Progetto
Consultazione 2017/64: Revisione dell'ordinanza del DFI sulla cartella informatizzata del paziente: introduzione dei formati di scambio elettronici · 172 pagine
Fedlex · Progetto · Pagina 3Fedlex · Progetto
Supplemento 2 all’allegato 4 OCIP-DFI: Cartella farmacologica informatizzata RS 816.111
1.4.8. IHE Patient Medication Instructions (1.3.6.1.4.1.19376.1.5.3.1.4.3) ......................................... 97 1.4.9. IHE Severity Entry (1.3.6.1.4.1.19376.1.5.3.1.4.1).................................................................... 99 1.4.10. Manufactured Material Entry Content Module (2.16.756.5.30.1.1.10.4.33) ............................ 101 1.4.11. Medication Treatment Plan Item Entry Content Module (2.16.756.5.30.1.1.10.4.34) ............. 105 1.4.12. MTP Reference Entry Content Module (2.16.756.5.30.1.1.10.4.45) ....................................... 113 1.4.13. PADV Reference Entry Content Module (2.16.756.5.30.1.1.10.4.53)..................................... 115 1.4.14. Pharmaceutical Advice Item Entry Content Module (2.16.756.5.30.1.1.10.4.44) ................... 116 1.4.15. PRE Reference Entry Content Module (2.16.756.5.30.1.1.10.4.47) ....................................... 125 1.4.16. Prescribed Quantity Entry Content Module (2.16.756.5.30.1.1.10.4.38) ................................ 127 1.4.17. Prescription Item Entry Content Module (2.16.756.5.30.1.1.10.4.43) ..................................... 128 1.4.18. Substitution Permission Entry Content Module (2.16.756.5.30.1.1.10.4.39) .......................... 138 1.4.19. Treatment Reason Entry Content Module (2.16.756.5.30.1.1.10.4.41) .................................. 140
2. Valuesets ............................................................................................................................................... 141 2.1. ActSubstanceAdminSubstitutionCode (2.16.840.1.113883.1.11.16621) ........................................ 142 2.2. DispenseSupplyType (2.16.756.5.30.1.127.77.4.11.7) ................................................................... 142 2.3. eMedicationCommentType (2.16.756.5.30.1.127.77.4.11.3) .......................................................... 143 2.4. HumanLanguage (2.16.840.1.113883.1.11.11526) ........................................................................ 144 2.5. ProblemType (2.16.756.5.30.1.127.77.4.11.4)................................................................................ 144 2.6. RouteOfAdministration (2.16.840.1.113883.1.11.14581) ................................................................ 145 2.7. SeverityObservation (2.16.840.1.113883.1.11.16643).................................................................... 169 2.8. TimingEvent (2.16.756.5.30.1.127.77.4.11.2) ................................................................................. 170